Cytodyn Inc at Cytodyn Inc Next Super Stock Live Hosted by Wall Street Reporter Transcript
Good afternoon, everybody, and welcome to Wall Street Reporter's Next Super Stock conference for January 23, 2020. Today, we have a special presentation by Dr. Nader Pourhassan of CytoDyn, stock symbol is CYDY.
As most of you know, CytoDyn has a blockbuster potential portfolio of really exciting drugs in the pipeline for cancer, HIV. They just signed an $87.5 million licensing deal and CytoDyn has been a regular presenter at our events and those of you have been following us have probably noticed the stock going from $0.35 last time Dr. Pourhassan was here in November to recent the trade of I think [$1.11] this morning. Looks like this could be just the beginning.
So, for those of you who are new to Wall Street Reporter, the premise of the Next Super Stock conference is simple. We're looking for companies with big upside potential going after billion-dollar opportunities. Most importantly, right now they're positioned at key inflection points with really transformative growth potential ahead. And most importantly, they have CEOs and management
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
